Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibition of neovascularization using VEGF-specific oligonucleotides

Inhibition of neovascularization using VEGF-specific oligonucleotides

US Patent 5801156 · Granted Sep 1, 1998

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

ApoM-Fc fusion proteins for treating lung diseases2025
Resonance Raman spectroscopy for evaluating mitochondrial function2025
Frataxin expression constructs2024
FFA1 (GPR40) as a therapeutic target for neural angiogenesis diseases or disorde2023
Frataxin expression constructs2021
Methods for treatment of complications of prematurity comprising administration 2016
Method and product for treatment and/or prevention of complications of prematuri2013
Detection of oligonucleotides by dual hybridization2010
Methods for decreasing risk of complications of prematurity using IGF-I and its 2010
Determination of risk and treatment of complications of prematurity2006
Modified VEGF Oligonucleotides for Inhibition of tumor growth2003
Antisense oligonucleotide inhibition of vascular endothelial growth factor expre2002